Goldline Pharmaceutical IPO Allotment Chances
Category-wise allotment probability for Goldline Pharmaceutical SME IPO, estimated from live subscription data. Use the dropdown to check another IPO.
Goldline Pharmaceutical IPO
Listed SMEPrice Band
Rs 41 - 43
Lot Size
TBA
Total Subscription
781.63x
Allotment Chances — Goldline Pharmaceutical IPO
Retail
0.13%
(880.68x subscribed)
Low chance
S-HNI (2-10L)
0.06%
(1,662.35x subscribed)
Low chance
B-HNI (>10L)
0.30%
(1,662.35x subscribed)
Low chance
If 100 retail investors apply, approximately 1 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results.
Actual allotment depends on the number of applications received and SEBI's allotment rules —
draw of lots for Retail, Employee and NII; proportionate for QIB.
Explore More
Quick links to all IPO sections
Open IPO
Live now
Best IPO Today
Top picks
Upcoming IPO
Coming soon
IPO Calendar
Dates & schedule
Closed IPO
Allotment pending
Listed IPO
Listing gains
IPO GMP
Grey market premium
Subscription
Live bidding data
Allotment
Check status
SME IPO
Small & medium
Mainboard IPO
Large cap
Performance
Listing returns
Learn
IPO guides
How these Goldline Pharmaceutical figures are worked out
Chances start from 1 ÷ subscription times, corrected per category — B-HNI bid above ₹10 lakh but are allotted the same minimum NII lot as an S-HNI, so their real odds run several times better than the raw figure implies. The corrections are measured against published basis-of-allotment documents, not assumed. Read the full method and the measured figures, or see allotment chances for every open IPO.